Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Evaluate the Effectiveness of Thermalytix (AI-based Thermographic Solution Developed by Niramai) for Breast Cancer Screening as Compared to Standard Screening Modalities for Breast Cancer

NCT04688086 is registered in ClinicalTrials.gov with Niramai Health Analytix Private Limited as lead sponsor.

NCT NCT04688086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04688086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Evaluate the Effectiveness of Thermalytix (AI-based Thermographic Solution Developed by Niramai) for Breast Cancer Screening as Compared to Standard Screening Modalities for Breast Cancer
Lead sponsor
Niramai Health Analytix Private Limited
Phase
Observational
Overall status
Completed
Start date
December 15, 2018
Completion date
January 30, 2020
Enrollment
687 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, early detection of cancer